RemedyRepack Inc. is recalling 1,858 units of Clindamycin HCl (300 mg) capsules because the medication was processed under conditions that deviated from Current Good Manufacturing Practice (CGMP) standards. The prescription antibiotic was repackaged into 30-count blister cards at the company's facility in Indiana, Pennsylvania. Because these standards were not met, the manufacturer cannot guarantee the drug's safety, quality, or effectiveness.
Failure to follow proper manufacturing and packaging procedures can result in medication that is contaminated, ineffective, or of inconsistent quality. While no specific injuries have been reported, using medication that does not meet safety standards poses a potential health risk.
You have 2 options:
Repackaged by RemedyRepack Inc. in Indiana, PA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.